GoVal Blogs
Expert articles on Computer System Validation, Computer Software Assurance, GAMP 5, 21 CFR Part 11, and modern GxP compliance.
Agile Validation in Pharma: How CSA Enables Faster, Iterative Development
Agile and GxP are not incompatible — but the combination requires more than good intentions. GAMP 5 Second Edition formally endorses iterative development for the first time. Here's what a GxP sprint actually looks like, and why CSA is what makes it feasible.
AI Validation in GxP: What FDA's 2026 Guidance Actually Requires
The January 2026 FDA/EMA joint principles on Good AI Practice are not about using AI to speed up validation — they're about what you need to prove when AI itself is the system being validated in a GxP environment. Here's what that actually requires.
Automated Requirements Traceability: How Live RTM Replaces Manual Matrix Maintenance in CSV
A manual RTM answers the question 'did we test everything?' at a point in time. A live RTM answers it continuously. The gap between those two states is exactly where inspectors find traceability failures — and where most pharma teams are still operating.
Change Control in Validated GxP Systems: What Triggers Revalidation and What Doesn't
Not every change to a validated GxP system requires revalidation — but every change requires an assessment to prove that. Here's the actual decision logic: what counts as a GxP-impacting change, what doesn't, and where teams get the classification wrong.
Digital Cleaning Validation: Why Paper-Based CV Is Now an Inspection Risk
Paper-based cleaning validation creates traceability gaps that inspectors now actively look for. Digital cleaning validation closes them — here's what actually changes when you move execution, sampling, and acceptance criteria onto a live system.
Ultimate Guide to Computer System Validation (CSV) in Pharma
Computer System Validation is not a one-time project — it is a continuous programme that governs every GxP software system in your environment. This guide covers everything: what CSV requires, how GAMP 5 and FDA CSA change the approach, what IQ/OQ/PQ actually demands, and how to build a validation programme that holds up under inspection.
What Is Critical Thinking in Computer Software Assurance?
Critical thinking in CSA is not a mindset — it is a documented, inspection-ready deliverable. Here is what FDA expects, what it looks like in practice, and why most pharma teams are still getting it wrong.
Manual Validation vs CSA-Driven Digital Validation: What Pharma Teams Must Know
Manual validation buries pharma teams in binders and slows every system change to a crawl. CSA-driven digital validation changes the fundamental equation — here's what that shift looks like in practice.
How to Implement Computer Software Assurance (CSA) in GxP Environments: A Practical Guide
CSA isn't a document to read — it's a practice to build. Most teams understand what CSA requires. Far fewer have a clear path from their current CSV environment to a compliant, inspection-ready CSA programme. This guide covers that path.
CSA-Ready VLMS: What to Look for in a Validation Platform Built for Computer Software Assurance
Not every validation platform supports CSA. Most were built for document-heavy CSV — and retrofitting them for risk-based assurance creates more overhead, not less. Here's what a genuinely CSA-ready VLMS must do, and how to evaluate one.
GxP Compliance Software: What Every Pharma Team Needs to Know
Manual validation processes can't enforce the contemporaneous capture, attributability, or traceability regulators expect. Here's what GxP compliance software actually does — and what separates platforms that enforce compliance from ones that just store documents.
Explaining Commissioning, Qualification, and Validation (CQV) in Pharma
CQV is not one process — it's three distinct phases that work together to ensure pharma facilities, systems, and equipment consistently produce safe, compliant products. Here's how they differ and why each matters.
Unscripted Testing in CSA: When to Use It and How to Document It
Unscripted testing is one of CSA's most misunderstood tools. It's not informal testing — it's structured exploratory testing with a documented rationale. Here's when it applies and how to make it inspection-ready.
FDA Warning Letters: How to Respond and Stay Compliant
An FDA Warning Letter isn't the end — but your 15-day response determines whether it resolves or escalates. Here's what triggers them in validation and how to respond effectively.
EU Annex 11 vs 21 CFR Part 11: Key Differences for Global Pharma Operations
Operating across the US and EU means satisfying two different electronic records frameworks simultaneously. Here's exactly where EU Annex 11 and 21 CFR Part 11 differ — and where they align.
Paperless Validation in Pharma: Benefits, Challenges, and How to Get Started
Paper-based validation creates audit risk, FTE overhead, and data integrity gaps that most teams underestimate. Here's what paperless validation actually delivers — and the practical steps to get there.
Risk-Based Approach to Validation: How to Do More with Less Documentation
A risk-based validation approach isn't about cutting corners. It's about directing rigour where it actually protects patients — and reducing overhead where it doesn't. Here's how to do it in practice.
Excel, Word & SharePoint vs GoVal: Why Life Sciences Teams Are Switching to Specialized Validation Software
Excel, Word, and SharePoint weren't built for GxP validation. Here's what that actually costs you — in audit risk, data integrity gaps, and compliance overhead — and what purpose-built validation software changes.
FDA CSA Final Guidance 2025: What Validation Professionals Need to Know
The FDA finalised its Computer Software Assurance guidance in September 2025. Here's what changed, what stayed the same, and what your validation programme needs to do differently starting now.
What Is Computer Software Assurance (CSA)?
CSA isn't just 'less CSV.' It's a fundamentally different way of thinking about software validation in GxP environments. Here's what it actually means — without the regulatory jargon.
ALCOA+ to ALCOA++: What's New and Why It Matters for Your Validation System
ALCOA++ isn't a name change — it adds three new principles that shift data integrity from document control to system-level assurance. Here's what changed and what your validation platform needs to handle.
Cleaning Validation in Pharma: A Complete Guide for 2026
Cleaning validation proves your equipment cleaning procedures consistently remove residues to safe, pre-defined levels. Here's what regulators require, how to set HBEL-based acceptance criteria, and where most facilities still get it wrong.
The ROI of Paperless Validation in Pharma: What the Numbers Actually Show
Paper validation consumes over 20% of project budgets and produces audit trails inspectors routinely challenge. The ROI of going paperless is documented — here's what the numbers show.
Validation Software for Biotech Companies: What to Look for in 2026
Biotech validation is faster, more complex, and under more regulatory scrutiny than ever. Here's what your validation platform needs to handle — and where generic tools fall short.
Pharma Validation Software Comparison 2026: What to Look For and Why GoVal Leads
With FDA CSA guidance finalised in September 2025, choosing the right VLMS has never been more consequential. This guide covers what matters in 2026 — and why GoVal is purpose-built to lead on every criterion that counts.
Validation Lifecycle Management System (VLMS) 2026: What It Is and Why It Matters
A VLMS maintains a continuous, current record of the validation state of every GxP system in your environment. Without one, the gap between the compliance state you believe you're in and the state you're actually in becomes visible only when an inspector arrives.
Equipment Validation in Pharma 2026: IQ OQ PQ Complete Guide
Equipment validation is inspection-scrutinised for one reason: the ongoing programme is harder to maintain than the initial qualification. This guide covers IQ, OQ, and PQ — and more critically, the change control, calibration, and periodic review programme that keeps equipment in a validated state.
Digital Validation Software for Life Sciences 2026: How to Choose the Right Platform
Digital validation software promises faster cycles and easier audits. The platforms that deliver on that promise share five specific characteristics. The ones that don't share one: they digitise your existing paper process and call it transformation.
Computer System Validation Software 2026: What It Does and How to Choose
Not all computer system validation software is equal. Some are purpose-built VLMS platforms. Others are document management tools with a pharma marketing layer. This guide shows you how to tell the difference — and exactly what the gaps cost you in inspection findings.
Computer Software Assurance for Production & Quality Systems: 2026 Practical Guide
FDA's CSA guidance finalised September 2025 changed how pharma teams validate MES, QMS, and LIMS. Most teams still apply the old CSV approach to everything. Here is exactly what CSA means for your production and quality software in 2026.
IQ OQ PQ Validation 2026: Complete Guide for Pharma & Life Sciences
IQ, OQ, and PQ are the three qualification phases every pharma validation team executes — but FDA 483 observations show the same six gaps recurring in qualification packages across the industry. This guide covers what each phase requires and exactly which mistakes to avoid.
FDA 21 CFR Part 11 Compliance Checklist 2026: Electronic Records & E-Signatures
The FDA cited Part 11 gaps in over 30% of pharma software inspections in 2025. Use this checklist to find every gap in your audit trails, e-signatures, and access controls before an inspector does.
GAMP 5 Categories Explained 2026: Real Software Examples for Each Category
GAMP 5 tells you to match validation effort to software risk — but which category does your LIMS, ERP, or custom automation script actually fall under? Every category explained with 2026 pharma software examples and exactly what validation each requires.
CSV vs CSA: Key Differences Every Life Sciences Team Must Know
CSV and CSA both aim for compliant software — but differ fundamentally in philosophy, effort, and risk approach. Here is what every pharma and life sciences team needs to understand before choosing one.
A Unified Approach to GxP Validation: Biotech, Medical Devices & Clinical Trials
Master GxP compliance across diverse Life Sciences sectors. Learn how a unified validation platform streamlines biotechnology validation, medical device validation, and clinical trial validation with tailored, risk-based workflows.
Mastering Hybrid Validation: How GoVal Bridges CSV and CSA
Learn how a hybrid validation deployment blends traditional CSV with modern CSA. Discover how GoVal's VLMS enables a flexible, risk-based approach with configurable workflows, dynamic risk assessment, and adaptable testing protocols.
Validation Debt in CSV: How to Eliminate It with GoVal (VLMS + AI)
What validation debt is and how GoVal’s VLMS and AI reduce it—automated traceability, evidence capture, e-signatures, and risk-based testing aligned with 21 CFR Part 11 & EU Annex 11.
Achieving 21 CFR Part 11 Regulation with Paperless Validation Software
Learn how paperless validation, electronic records, and audit trails ensure 21 CFR Part 11 compliance.
Revolutionizing Validation with AI: GoVal's Intelligent Approach
In the dynamic landscape of the life sciences industry, ensuring the quality and compliance of computer systems is paramount. Traditional validation processes are time-consuming and error-prone.
Smart Implementation of Paperless Validation: A Strategic Approach | GoVal
Implementing a paperless validation solution is crucial for modern life science organizations seeking to streamline GxP compliance and enhance efficiency. This article outlines a smart, risk-based approach to ensure a successful transition to digital validation, optimizing your validation lifecycle management (VLMS).
Streamline Test Case Management: A Guide with GoVal
In the world of computer system validation (CSV), efficient test case management is paramount. Manual processes are often riddled with delays and inconsistencies.
Digital Validation: Transforming Life Sciences with Traceability & Audits
In the fast-paced world of life sciences, the transition from paper to digital validation is no longer optional. It’s essential for maintaining audit readiness.
Revolutionize Computer System Validation in Life Sciences with GoVal
In the demanding pharma and life sciences sectors, robust computer system validation is essential for compliance and efficiency. GoVal simplifies the process.
Best Kneat Alternative for GxP Validation in 2026
Kneat is strong on protocol execution, but life sciences teams that need built-in AI, risk-based CSV, and transparent pricing are switching to GoVal.
ValGenesis Alternative: Why Pharma Teams Choose GoVal
ValGenesis dominates the enterprise VLMS space — but its licensing complexity and implementation timelines leave mid-sized pharma and biotech teams underserved.
MasterControl Alternative: Purpose-Built Validation
MasterControl is a QMS platform with validation bolted on. GoVal is a purpose-built VLMS. Get deeper compliance, AI automation, and up to 60% lower cost.
Ready to modernize your validation?
Join top pharma teams using GoVal to eliminate paper, ensure compliance, and streamline 21 CFR Part 11 workflows.